Literature DB >> 24326381

Incidence of whooping cough in Spain (1997-2010): an underreported disease.

María Isabel Fernández-Cano1, Lluís Armadans Gil, Xavi Martínez Gómez, Magda Campins Martí.   

Abstract

UNLABELLED: Whooping cough is currently the worst controlled vaccine-preventable disease in the majority of countries. In order to reduce its morbidity and mortality, it is essential to adapt vaccination programmes to data provided by epidemiological surveillance. A population-based retrospective epidemiological study to estimate the minimum annual undernotification rate of pertussis in Spain from 1997 to 2010 was performed. The incidence of pertussis cases reported to the National Notifiable Disease Surveillance System was compared with the incidence of hospital discharges for pertussis from the National Surveillance System for hospital data, Conjunto Mínimo Básico de Datos. The overall reported incidence and that of hospitalisation for whooping cough were 1.3 cases × 100,000 inhabitants in both cases. Minimum underreporting oscillated between 3.8 and 22.8 %, according to the year of the study. The greatest underreporting (50 %) was observed in children under the age of 1 year.
CONCLUSION: Spanish epidemiological surveillance system of pertussis should be improved with complementary active systems to ascertain the real incidence. Paediatricians and general practitioners should be sensibilized to the importance of notification because this would be essential for adapting the prevention and control measures of this disease.

Entities:  

Mesh:

Year:  2013        PMID: 24326381     DOI: 10.1007/s00431-013-2228-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  20 in total

1.  Do variations in pertussis notifications reflect incidence or surveillance practices? A comparison of infant notification rates and hospitalisation data in NSW.

Authors:  Siranda Torvaldsen; Peter McIntyre
Journal:  N S W Public Health Bull       Date:  2003 Apr-May

2.  Has pertussis increased in NSW over the past decade? An evaluation using hospitalisation and mortality data versus notifications 1988-2002.

Authors:  Rob Menzies; Han Wang; Peter McIntyre
Journal:  N S W Public Health Bull       Date:  2003 Apr-May

3.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-06-29       Impact factor: 17.586

Review 4.  Changing epidemiology and emerging risk groups for pertussis.

Authors:  Eleni Galanis; Arlene S King; Paul Varughese; Scott Alan Halperin
Journal:  CMAJ       Date:  2006-02-14       Impact factor: 8.262

5.  Pertussis epidemic--Washington, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-07-20       Impact factor: 17.586

6.  Pertussis knowledge, attitude and practices among European health care professionals in charge of adult vaccination.

Authors:  Muriel Hoffait; David Hanlon; Bernd Benninghoff; Stijn Calcoen
Journal:  Hum Vaccin       Date:  2011-02-01

7.  Use of hospital discharge data to evaluate notifiable disease reporting to Colorado's Electronic Disease Reporting System.

Authors:  Tegan K Boehmer; Jennifer L Patnaik; Steven J Burnite; Tista S Ghosh; Ken Gershman; Richard L Vogt
Journal:  Public Health Rep       Date:  2011 Jan-Feb       Impact factor: 2.792

8.  Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000.

Authors:  Li Liu; Hope L Johnson; Simon Cousens; Jamie Perin; Susana Scott; Joy E Lawn; Igor Rudan; Harry Campbell; Richard Cibulskis; Mengying Li; Colin Mathers; Robert E Black
Journal:  Lancet       Date:  2012-05-11       Impact factor: 79.321

9.  Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011.

Authors:  James D Cherry; Tina Tan; Carl-Heinz Wirsing von König; Kevin D Forsyth; Usa Thisyakorn; David Greenberg; David Johnson; Colin Marchant; Stanley Plotkin
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

10.  Hospitalization for pertussis: profiles and case costs by age.

Authors:  Judith A O'Brien; J Jaime Caro
Journal:  BMC Infect Dis       Date:  2005-07-11       Impact factor: 3.090

View more
  5 in total

Review 1.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

2.  Direct Medical Costs of Four Vaccine-Preventable Infectious Diseases in Older Adults in Spain.

Authors:  Ángel Gil de Miguel; José María Eiros Bouza; Luis Ignacio Martínez Alcorta; Daniel Callejo; Carlos Miñarro; Laura Amanda Vallejo-Aparicio; Andrea García; Mónica Tafalla; María Del Rosario Cambronero; Rubén Rodríguez; Laura Martin-Gomez
Journal:  Pharmacoecon Open       Date:  2022-03-07

3.  Forecasting the future number of pertussis cases using data from Google Trends.

Authors:  Dominik Nann; Mark Walker; Leonie Frauenfeld; Tamás Ferenci; Mihály Sulyok
Journal:  Heliyon       Date:  2021-11-12

4.  Under-reporting of notifiable infectious disease hospitalizations: significant improvements in the Irish context.

Authors:  E D Brabazon; A Sheridan; P Finnegan; M W Carton; D Bedford
Journal:  Epidemiol Infect       Date:  2014-07-18       Impact factor: 4.434

5.  Characteristics of Hospitalized Cases of Pertussis in Catalonia and Navarra, Two Regions in the North of Spain.

Authors:  Inma Crespo; Diana Toledo; Núria Soldevila; Iolanda Jordán; Rubén Solano; Jesús Castilla; Joan A Caylà; Pere Godoy; Carmen Muñoz-Almagro; Ángela Domínguez
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.